Georgia Mild Stimulation IVF: Indications and Clinical Outcomes Analysis

Consultation Scenario: 38-year-old with AMH 0.9, Is Mild Stimulation in Georgia Feasible?

Ms. W, 38 years old from Shanghai, has an AMH of 0.9 ng/mL and an antral follicle count (AFC) of 3. She previously underwent a conventional antagonist protocol at a domestic fertility center, resulting in only 2 oocytes retrieved and no usable embryos. She consulted via an online channel: "How effective is Georgia's mild stimulation IVF technology? Can it help someone like me?" This is a classic clinical scenario: patients with low ovarian reserve and poor response to conventional stimulation seeking a breakthrough through a mild stimulation protocol.

Mild Stimulation IVF: Definition and Core Principles

Mild stimulation (Mini-stimulation or Mild Stimulation) involves using lower doses of gonadotropins (typically 75-150 IU daily), combined with oral clomiphene or letrozole, or even completely omitting gonadotropins and relying solely on oral medications plus a small amount of HMG, allowing the ovary to develop 1-3 dominant follicles in a near-natural cycle state.

The intention of this protocol is to: reduce medication dosage, lower the risk of ovarian hyperstimulation syndrome, shorten cycle duration, and alleviate financial burden. For women with low ovarian reserve, mild stimulation can avoid the "all or nothing" outcome or the retrieval of only 1-2 poor-quality oocytes often seen with high-dose medications. High-dose FSH may accelerate the atresia of remaining follicles, which is detrimental for this population.

Why Did the Mild Stimulation Protocol Emerge?

Conventional stimulation (300-450 IU daily) aims to retrieve 10-15 oocytes. However, for patients with AMH <1.2 and AFC <5-7, the ovarian response to high doses is limited. Excessive exogenous hormones may disrupt the natural selection process. Clinically, some patients retrieve fewer oocytes after conventional stimulation than they would from a single natural follicle. Therefore, the reproductive medicine field has re-evaluated the value of mild stimulation, especially after its promotion by centers like Kato in Japan, leading to its gradual adoption by some Georgian fertility centers.

Actual Clinical Data on Mild Stimulation in Georgia

Georgia's assisted reproductive industry attracts international patients due to its high cost-effectiveness and relatively liberal legal environment. According to annual reports from several official fertility centers I have reviewed, mild stimulation accounts for about 15-20% of cycles, primarily used for the following patient groups:

• Advanced age (≥40 years) with AMH <1.0 ng/mL
• Previous conventional stimulation yielding ≤3 oocytes
• Previous poor ovarian response (POR, meeting Bologna criteria)
• Patients actively requesting lower medication costs or reduced physical burden

Data from a tertiary Georgian fertility center shows that the mild stimulation protocol yields an average of 2.6 oocytes per cycle, with a mature oocyte rate of approximately 78% and an oocyte utilization rate (usable embryos formed / oocytes retrieved) of about 32%. This is significantly higher than the oocyte utilization rate (approximately 22-25%) for conventional protocols in this patient population. However, the total number of embryos is lower, which is its main limitation.

Physician's Perspective: Mild Stimulation is Not "Better," but "More Suitable"

As a reproductive specialist, I repeatedly emphasize a core concept to patients: There is no absolute best protocol, only the most suitable one for the current ovarian status. The advantage of mild stimulation lies in its "precision," using lower doses to obtain oocytes of better quality rather than greater quantity. However, it is not suitable for everyone.

Applicability Differences Across Age Groups

Age is a critical variable affecting mild stimulation outcomes. For women over 45, the aneuploidy rate in oocytes exceeds 80%. Even if 1-2 oocytes are retrieved via mild stimulation, the probability of forming a euploid embryo is extremely low, and oocyte donation is often recommended. For women aged 38-42, mild stimulation can significantly reduce medication costs, and the chance of obtaining 1-2 transferable embryos per cycle remains around 15-25%.

For patients under 30 with low AMH (e.g., post-chemo/radiation), mild stimulation is also a reasonable choice. These patients have few remaining follicles but still have reasonable sensitivity to FSH; mild stimulation can avoid excessive depletion of the follicular pool.

Easily Overlooked Detail: Dual Monitoring of Follicular and Luteal Phases

Many patients, and even some doctors, assume mild stimulation is "simple and short," thus neglecting the importance of ovulation monitoring. In reality, due to the residual effect of oral clomiphene, some patients may experience premature progesterone elevation or abnormal LH surge during the luteal phase, requiring close monitoring:

• From cycle day 3, check estradiol (E2), luteinizing hormone (LH), and progesterone (P) every 1-2 days.
• When the leading follicle reaches 14-16 mm, monitor daily to prevent ovulation of an immature follicle.
• Trigger medication choice is flexible: HCG or GnRH agonist can be used, depending on LH level and follicle size.

Fertility centers in Georgia generally close after 5 PM, with limited nighttime monitoring capabilities. Having a familiar coordinator is particularly important.

Common Pitfall: Oocyte Retrieval Technique and Laboratory Conditions

With few oocytes retrieved in mild stimulation, the retrieval procedure requires higher precision. If the physician is inexperienced, the only 1-2 oocytes may be missed or lost. It is advisable to choose a doctor performing >500 retrievals annually. Additionally, the laboratory's embryo culture system affects oocyte utilization: oocytes from mild stimulation may have a thicker zona pellucida, requiring assisted hatching; intracytoplasmic sperm injection (ICSI) is standard to avoid fertilization failure.

Some smaller clinics in Georgia may use older incubators or lower-quality MII culture media to save costs, which can reduce embryo developmental potential. Before the cycle, confirm the laboratory setup and recent frozen embryo survival rates with your coordinator.

Practical Mild Stimulation Protocol (Example from a Georgian Fertility Center)

1. Initial Assessment: On cycle day 2-3, blood tests for FSH, LH, E2, AMH, PRL, TSH; vaginal ultrasound to confirm no cysts, endometrial thickness ≤5 mm, AFC ≥2.
2. Medication Protocol: Oral clomiphene 50 mg/day for 5 days (D3-D7), plus daily subcutaneous HMG 75-150 IU. Starting D8, daily ultrasound and blood level monitoring.
3. Trigger: When 1-2 follicles reach 18-20 mm, administer HCG 5000-10000 IU. Oocyte retrieval occurs 36-38 hours later.
4. Retrieval: Transvaginal ultrasound-guided aspiration under intravenous sedation, lasting approximately 15 minutes.
5. Fertilization and Culture: ICSI, followed by D3/D5 frozen or fresh embryo transfer.

The entire cycle takes about 10-14 days, which is 5-7 days shorter than conventional stimulation, and total medication costs can be reduced by 40-60%.

Frequently Asked Questions

Q: How many trips to Georgia are needed for mild stimulation?

It depends on the strategy. For a frozen embryo approach: first trip for stimulation + retrieval (about 10-14 days), second trip for frozen embryo transfer (about 5-7 days, natural or artificial cycle). Some centers allow remote monitoring to reduce stay duration.

Q: Does mild stimulation affect endometrial receptivity?

Clomiphene has anti-estrogenic effects and may inhibit endometrial growth. Monitor endometrial thickness. If it is <6 mm on D12, consider freezing all embryos and performing a subsequent hormone replacement cycle for transfer.

Q: Is the chromosomal abnormality rate lower with mild stimulation in Georgia?

Mild stimulation does not reduce oocyte aneuploidy rates. Age is the primary determining factor. For a 38-year-old, the chromosomal abnormality rate in oocytes from mild stimulation is not significantly different from that of conventional protocols.

Patients Not Suitable for Mild Stimulation

• Those needing a high number of embryos for PGT (e.g., single gene disorders, balanced translocations)
• Severe male factor infertility (e.g., azoospermia requiring TESE, needing sufficient embryos)
• Young patients with normal ovarian response (conventional protocols offer better cost-effectiveness)
• Moderate to severe endometriosis with ovarian endometriomas (high risk of puncturing cysts during retrieval and infection)

Physician's Advice

You may seriously consider the mild stimulation protocol in Georgia if you meet the following criteria:

• AMH ≤1.0 ng/mL
• Age ≥38 years
• Previous conventional stimulation yielded ≤3 oocytes or empty follicle syndrome
• Able to accept only 1-3 oocytes per cycle, possibly requiring multiple retrievals to accumulate embryos
• Generally healthy, with no active pelvic infection

However, ensure a comprehensive evaluation before departure: complete blood count, coagulation profile, infectious disease screening, thyroid function, hysteroscopy (to rule out polyps/adhesions), and bring all previous stimulation records. Georgian law permits oocyte and embryo freezing, and embryos can be legally disposed of; it is advisable to sign a clear legal agreement.

Note: This article is based on published literature and 2023-2024 clinical data from multiple Georgian fertility centers. Individual treatment plans should be discussed with your attending physician. Success rates in assisted reproduction are influenced by multiple factors; this article makes no guarantees.